<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"></head><body style="word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;" class=""><div class="">Dems — 62% support, 15% oppose</div><div class="">Reps — 41% support, 32% oppose</div><div class="">All Voters — 52% support, 23% oppose</div><div class=""><br class=""></div><div class=""><br class=""></div><div class=""><a href="https://morningconsult.com/2022/02/09/coronavirus-vaccines-patent-rights-waiver-polling/" class="">https://morningconsult.com/2022/02/09/coronavirus-vaccines-patent-rights-waiver-polling/</a></div><div class=""><br class=""></div><div class=""><br class=""></div><div class=""><h3 class="single-hero__label" style="box-sizing: border-box; margin: 0px; padding: 0px; font-size: 0.7rem; font-family: "Proxima Nova"; letter-spacing: 0.15em; line-height: 1; text-transform: uppercase; color: rgb(43, 43, 43);">VACCINES</h3><h1 class="single-hero__title" style="box-sizing: border-box; font-size: 1.85rem; margin: 0.75rem 0px; padding: 0px; font-family: "EB Garamond"; line-height: 1.3;">2 in 3 Democrats and 2 in 5 Republicans Back Proposal to Waive COVID-19 Vaccine Patent Rights</h1><h2 class="single-hero__subhead" style="box-sizing: border-box; font-weight: 400; margin: 0px; padding: 0px; font-size: 1rem; font-family: "Proxima Nova"; line-height: 1.15;">Increase in overall voter support from May 2021 driven by uptick among Republicans</h2><div class=""><br class=""></div></div><div class=""><br class=""></div><div class=""><div class="h3 large" style="box-sizing: border-box; font-size: 1.1rem; font-family: "Proxima Nova"; letter-spacing: 0.15em; line-height: 1; font-weight: 700; text-transform: uppercase;"><span style="box-sizing: border-box;" class="">BY </span><a class="single-author__link" href="https://morningconsult.com/author/ggalvin/" target="_blank" style="box-sizing: border-box; text-decoration-skip: objects; color: rgb(0, 0, 0); text-decoration: none; transition: color 0.3s;">GABY GALVIN</a></div><div class="single-date" style="box-sizing: border-box; font-size: 0.8rem; color: rgb(117, 117, 117); margin: 0.5rem 0px 0px; font-family: "Proxima Nova";">February 9, 2022 at 6:00 am ET</div></div><div class="single-date" style="box-sizing: border-box; font-size: 0.8rem; color: rgb(117, 117, 117); margin: 0.5rem 0px 0px; font-family: "Proxima Nova";"><br class=""></div><div class=""><span style="font-family: "Proxima Nova"; font-size: 18px; background-color: rgb(255, 255, 255);" class="">About half of voters are in favor of a proposal for the World Trade Organization to temporarily waive patent rights for COVID-19 vaccines in a bid to shore up production of the shots in lower-income countries, according to new Morning Consult/Politico </span><a href="https://assets.morningconsult.com/wp-uploads/2022/02/08222920/2202029_crosstabs_POLITICO_RVs_v2_SH.pdf" style="box-sizing: border-box; text-decoration-skip: objects; color: rgb(70, 87, 206); text-decoration: none; transition: color 0.3s; font-family: "Proxima Nova"; font-size: 18px;" class="">polling</a><span style="font-family: "Proxima Nova"; font-size: 18px; background-color: rgb(255, 255, 255);" class=""> that comes ahead of a global ruling on the issue.</span></div><div class=""><br class=""></div><div class=""><br class=""></div><div class="single-col__right content single-content__plain" style="box-sizing: border-box; padding: 0px 110px; grid-column-start: 1; grid-column-end: span 12; margin: 0px 0px 1.5rem;"><p style="box-sizing: border-box; font-size: 1rem; line-height: 1.5; letter-spacing: unset; text-transform: unset; margin: 0px 0px 1rem;" class=""><span style="box-sizing: border-box;" class="">What you need to know:</span></p><ul style="box-sizing: border-box; margin: 0px; padding: 0px 0px 0px 2rem; font-size: 1rem; line-height: 1.5; letter-spacing: unset; text-transform: unset;" class=""><li aria-level="1" style="box-sizing: border-box; margin: 0px 0px 1rem;" class=""><span style="box-sizing: border-box;" class="">Fifty-two percent of voters said they support a proposal that would allow the WTO to pause COVID-19 vaccine patent protections, up slightly from 48 percent who said the same in </span><a href="https://morningconsult.com/2021/05/12/covid-vaccine-patent-waiver-poll/" style="box-sizing: border-box; text-decoration-skip: objects; color: rgb(70, 87, 206); text-decoration: none; transition: color 0.3s;" class="">May 2021</a><span style="box-sizing: border-box;" class="">. The uptick was driven by an increase of 10 percentage points among Republicans, 41 percent of whom now say they’re in favor of temporarily waiving patent rights so developing countries can make the shots. Democratic voters remain more likely to support the proposal, at 66 percent.</span></li><li aria-level="1" style="box-sizing: border-box; margin: 0px 0px 1rem;" class=""><span style="box-sizing: border-box;" class="">About 1 in 3 Republican voters opposed the waiver proposal, virtually unchanged from May 2021, while 15 percent of Democrats said they were against it, a 5-point increase since last spring.</span></li><li aria-level="1" style="box-sizing: border-box; margin: 0px 0px 1rem;" class=""><span style="box-sizing: border-box;" class="">India and South Africa launched the waiver push in 2020, arguing it would help bridge gaps in global vaccine access by enabling lower-income countries to make their own COVID-19 shots, and WTO Director-General Ngozi Okonjo-Iweala said the group aims to </span><a href="https://www.wto.org/english/news_e/news22_e/gc_27jan22_e.htm" style="box-sizing: border-box; text-decoration-skip: objects; color: rgb(70, 87, 206); text-decoration: none; transition: color 0.3s;" class="">make a decision</a><span style="box-sizing: border-box;" class=""> by the end of February. Scientists in South Africa have </span><a href="https://www.reuters.com/world/africa/world-first-safricas-afrigen-makes-mrna-covid-vaccine-using-moderna-data-2022-02-03/" style="box-sizing: border-box; text-decoration-skip: objects; color: rgb(70, 87, 206); text-decoration: none; transition: color 0.3s;" class="">already developed</a><span style="box-sizing: border-box;" class=""> a copy of Moderna Inc.’s vaccine that could begin human trials this year, after Moderna and Pfizer Inc.-BioNTech SE declined to share their recipes.</span></li><li aria-level="1" style="box-sizing: border-box; margin: 0px 0px 1rem;" class=""><span style="box-sizing: border-box;" class="">President Joe Biden </span><a href="https://www.reuters.com/business/healthcare-pharmaceuticals/us-president-biden-calls-intellectual-property-protection-waivers-covid-19-2021-11-26/" style="box-sizing: border-box; text-decoration-skip: objects; color: rgb(70, 87, 206); text-decoration: none; transition: color 0.3s;" class="">reiterated his support</a><span style="box-sizing: border-box;" class=""> for the waiver when the omicron variant emerged in late November, and Democratic lawmakers </span><a href="https://thehill.com/policy/healthcare/582809-senate-dems-call-on-biden-to-push-for-covid-vaccine-patent-waivers-at-wto" style="box-sizing: border-box; text-decoration-skip: objects; color: rgb(70, 87, 206); text-decoration: none; transition: color 0.3s;" class="">have urged him</a><span style="box-sizing: border-box;" class=""> to reach an agreement with global leaders on a “meaningful waiver” to help increase COVID-19 vaccine production around the globe.</span></li><li aria-level="1" style="box-sizing: border-box; margin: 0px 0px 1rem;" class=""><span style="box-sizing: border-box;" class="">Republican lawmakers </span><a href="https://thehill.com/homenews/house/551769-house-republicans-urge-opposition-to-vaccine-patent-waiver" style="box-sizing: border-box; text-decoration-skip: objects; color: rgb(70, 87, 206); text-decoration: none; transition: color 0.3s;" class="">largely oppose</a><span style="box-sizing: border-box;" class=""> the waiver, as does the U.S. drug lobby. Last week, the Pharmaceutical Research and Manufacturers of America said that </span><a href="http://freepdfhosting.com/4ac4e90bb1.pdf" style="box-sizing: border-box; text-decoration-skip: objects; color: rgb(70, 87, 206); text-decoration: none; transition: color 0.3s;" class="">waiving patent protections</a><span style="box-sizing: border-box;" class=""> wouldn’t solve vaccine production and distribution bottlenecks and would instead “undermine the ability to respond to both the current pandemic and future health crises.”</span></li></ul><div style="box-sizing: border-box; font-size: 1rem; line-height: 1.5; letter-spacing: unset; text-transform: unset; margin: 0px;" class=""><em style="box-sizing: border-box;" class="">The May 7-9, 2021, and Feb. 5-6, 2022, polls were conducted among representative samples of about 2,000 registered voters each, with unweighted margins of error of plus or minus 2 percentage points.</em></div></div><div class="single-content__related single-col__right" style="box-sizing: border-box; border-top-width: 1px; border-top-style: solid; border-top-color: rgb(136, 136, 136); border-bottom-width: 1px; border-bottom-style: solid; border-bottom-color: rgb(136, 136, 136); grid-column-start: 1; margin: 0px 0px 1.5rem; padding: 0.75rem 1rem; grid-column-end: span 12;"><a class="single-content__related_link" href="https://morningconsult.com/2021/12/21/clinical-trials-poll-2022/" style="box-sizing: border-box; text-decoration-skip: objects; color: rgb(117, 117, 117); text-decoration: none; transition: color 0.3s; -webkit-box-align: center; align-items: center; display: flex; -webkit-box-pack: justify; justify-content: space-between; font-family: "Proxima Nova"; font-size: 18px;"></a></div><div class="">
Arthur Stamoulis<br class="">Citizens Trade Campaign<br class="">(202) 494-8826<br class=""><br class=""><br class=""><br class="">
</div>
<br class=""></body></html>